Among these, the combination of lycorine with NF-kB inhibitors is shown to offer a therapeutic effect against glioma by inhibiting C6 glioma cell growth and inducing cell apoptosis, as well as promoting intracellular reactive oxygen species (ROS) production [22]. Here, NFKB1 is linked to glioma.